China Everbright Limited (CEVIY)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
China Everbright Limited (CEVIY) with AI Score 51/100 (Hold). China Everbright Limited is an investment and financial services firm operating in Hong Kong and Mainland China. Market cap: 0, Sector: Financial services.
Last analyzed: Mar 16, 2026China Everbright Limited (CEVIY) Financial Services Profile
China Everbright Limited is a Hong Kong-based financial services firm specializing in asset management and direct investments across diverse sectors, including new economy, healthcare, and infrastructure. With a focus on both public and private equity, the company provides financial services and investment advisory in Hong Kong and Mainland China.
Investment Thesis
China Everbright Limited presents a mixed investment case. The company's diverse investment portfolio across high-growth sectors like AI and healthcare offers potential upside. However, a negative P/E ratio of -98.46 and a negative profit margin of -6.2% raise concerns about near-term profitability. The dividend yield of 1.26% provides some income, but investors should carefully weigh the risks against the potential rewards. Key catalysts include successful deployment of capital in its focus sectors and improved market conditions in China. Close monitoring of financial performance and macroeconomic factors is crucial.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.91 billion indicates its size within the asset management industry.
- Negative P/E ratio of -98.46 reflects current losses, requiring careful evaluation of future earnings potential.
- Gross margin of 61.4% demonstrates the company's ability to generate revenue efficiently.
- Dividend yield of 1.26% provides a modest income stream for investors.
- Beta of 0.78 suggests lower volatility compared to the overall market.
Competitors & Peers
Strengths
- Diversified investment portfolio across multiple sectors.
- Established presence in Hong Kong and Mainland China.
- Expertise in asset management and investment advisory services.
- Access to deal flow through its parent company.
Weaknesses
- Negative P/E ratio and profit margin raise concerns about profitability.
- Exposure to regulatory uncertainties in China.
- Dependence on macroeconomic conditions in the region.
- Limited geographic diversification outside of Asia.
Catalysts
- Ongoing: Expansion into high-growth sectors like AI and healthcare could drive revenue growth.
- Ongoing: Increasing demand for asset management services in China creates opportunities for growth.
- Upcoming: Potential strategic acquisitions to expand its investment portfolio in 2026.
- Ongoing: Development of new investment products and services to attract investors.
- Ongoing: Government support for key investment areas such as technology and healthcare.
Risks
- Ongoing: Negative P/E ratio and profit margin raise concerns about profitability.
- Potential: Economic slowdown in China could negatively impact investment performance.
- Potential: Geopolitical risks and trade tensions could disrupt business operations.
- Ongoing: Increased competition from other asset management firms.
- Potential: Regulatory changes in China could affect the company's operations.
Growth Opportunities
- Expansion into AI and IoT: China Everbright Limited's investment in artificial intelligence of things (AIoT) aligns with the growing demand for smart solutions across industries. The global AIoT market is projected to reach $107.7 billion by 2026, presenting a significant growth opportunity. Successful deployment of capital in this sector could drive revenue growth and enhance the company's technological capabilities.
- Healthcare and Senior Care Investments: The increasing aging population in China creates a growing demand for healthcare and senior care services. China Everbright Limited's focus on medical care and senior healthcare aligns with this demographic trend. The Chinese healthcare market is expected to reach $2.3 trillion by 2030, offering substantial growth potential for the company's investments in this sector.
- Aircraft Leasing Business: The global aircraft leasing market is expected to grow, driven by increasing air travel demand and airline fleet modernization. China Everbright Limited's involvement in aircraft leasing provides exposure to this growing market. The company can expand its leasing portfolio and capitalize on the demand for aircraft financing solutions.
- Overseas Acquisition and Infrastructure Investments: China Everbright Limited's strategy of investing in overseas acquisitions and infrastructure projects provides diversification and access to global growth opportunities. Infrastructure investments, particularly in emerging markets, offer long-term growth potential and stable returns. The company can leverage its expertise to identify and execute strategic acquisitions.
- Mezzanine Fund Investments: Investing in mezzanine funds allows China Everbright Limited to participate in leveraged buyouts and recapitalizations. Mezzanine debt offers attractive yields and downside protection. The company can generate income and capital appreciation through its mezzanine fund investments, contributing to overall portfolio performance.
Opportunities
- Expansion into high-growth sectors like AI and healthcare.
- Increasing demand for asset management services in China.
- Strategic acquisitions to expand its investment portfolio.
- Development of new investment products and services.
Threats
- Increased competition from other asset management firms.
- Economic slowdown in China.
- Geopolitical risks and trade tensions.
- Fluctuations in currency exchange rates.
Competitive Advantages
- Established presence in Hong Kong and Mainland China.
- Diversified investment portfolio across multiple sectors.
- Access to deal flow through its parent company, Honorich Holdings Limited.
- Expertise in asset management and investment advisory services.
About CEVIY
Founded in 1997 and headquartered in Hong Kong, China Everbright Limited operates as a subsidiary of Honorich Holdings Limited, engaging in investment activities and financial service provisions across Hong Kong and Mainland China. The company's investment portfolio spans unlisted equity securities and equity derivatives, with a strategic focus on emerging sectors such as new economy, artificial intelligence and advanced manufacturing, new energy, medical care and senior healthcare, overseas acquisition and infrastructure, real estate, aircraft industry chain, and mezzanine funds. China Everbright Limited also invests in aircraft leasing, artificial intelligence of things, and elderly care industry platforms, alongside equity, debts, structured products, and other financial instruments. Beyond direct investment, the company offers a suite of financial services, including asset management, investment management, and investment advisory services related to absolute return funds, bond funds, and equity funds. It also provides management, treasury management, money lending, fund management, property and project investment, venture capital, leasing, and consultancy services, positioning itself as a diversified financial services provider in the region.
What They Do
- Invests in unlisted equity securities and equity derivatives.
- Focuses on sectors like new economy, AI, advanced manufacturing, and new energy.
- Provides asset management services.
- Offers investment management services.
- Delivers investment advisory services.
- Engages in property and project investment.
- Offers venture capital and leasing services.
- Provides consultancy services.
Business Model
- Generates revenue through investment gains from its portfolio companies.
- Earns fees from asset management and investment advisory services.
- Receives income from leasing activities.
- Profits from property and project investments.
Industry Context
China Everbright Limited operates within the asset management industry, which is influenced by global economic trends, regulatory changes, and investor sentiment. The industry is experiencing growth in alternative investments and demand for ESG-focused funds. Competitors include firms like AJMPF and CYMBF, which also offer diverse investment products. China's economic growth and increasing wealth are driving demand for asset management services, but regulatory uncertainties and market volatility pose challenges.
Key Customers
- Institutional investors seeking asset management services.
- High-net-worth individuals looking for investment advisory services.
- Companies seeking venture capital and leasing solutions.
- Project developers requiring property investment.
Financials
Chart & Info
China Everbright Limited (CEVIY) stock price: Price data unavailable
Latest News
No recent news available for CEVIY.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CEVIY.
Price Targets
Wall Street price target analysis for CEVIY.
MoonshotScore
What does this score mean?
The MoonshotScore rates CEVIY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Leadership: Chun Lin
CEO
Chun Lin serves as the CEO of China Everbright Limited, overseeing the company's investment activities and financial service operations. His background includes extensive experience in the financial services industry, with a focus on asset management and investment banking. Before joining China Everbright Limited, Mr. Lin held leadership positions at various financial institutions, where he was responsible for strategic planning, business development, and risk management. He holds a degree in Finance from a reputable university.
Track Record: Under Chun Lin's leadership, China Everbright Limited has expanded its investment portfolio into emerging sectors such as AI and healthcare. He has focused on strengthening the company's asset management capabilities and expanding its presence in Mainland China. Key milestones include strategic acquisitions and successful deployment of capital in high-growth opportunities. He manages 242 employees.
China Everbright Limited ADR Information Unsponsored
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. CEVIY is an ADR representing shares of China Everbright Limited, allowing U.S. investors to invest in the company without directly dealing with foreign exchanges. The ADR is denominated in U.S. dollars, simplifying trading and settlement.
- Home Market Ticker: Hong Kong Stock Exchange (SEHK), Hong Kong
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: CEVI
CEVIY OTC Market Information
The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure and may not meet the listing requirements of major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the lack of regulatory oversight and potential for fraud or manipulation. Information availability is often limited, making due diligence crucial.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in CEVIY.
- Low liquidity can result in wider bid-ask spreads and price volatility.
- Potential for fraud or manipulation due to lack of regulatory oversight.
- Dependence on macroeconomic conditions in Hong Kong and Mainland China.
- Currency risk associated with fluctuations in the exchange rate.
- Verify the company's registration and legal standing.
- Obtain and review the company's financial statements, if available.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's risk factors and potential liabilities.
- Consult with a financial advisor before investing.
- Understand the trading mechanics and potential risks of OTC markets.
- Subsidiary of Honorich Holdings Limited.
- Established presence in Hong Kong and Mainland China.
- Involvement in asset management and investment advisory services.
- Investments in diverse sectors like AI and healthcare.
Common Questions About CEVIY
What does China Everbright Limited do?
China Everbright Limited is a diversified financial services company that operates primarily in Hong Kong and Mainland China. The company focuses on asset management, direct investment, and the provision of financial advisory services. Its investment portfolio spans various sectors, including new economy, artificial intelligence, healthcare, and infrastructure. Through its subsidiaries, the company offers a range of financial products and services to institutional and individual investors.
What do analysts say about CEVIY stock?
Analyst coverage of CEVIY stock is limited due to its OTC listing and lower trading volume. Key valuation metrics, such as the negative P/E ratio, suggest caution. Growth considerations include the company's investments in emerging sectors and its exposure to the Chinese economy. Investors should conduct thorough research and consider the risks associated with OTC stocks before making investment decisions. There is no strong consensus to buy or sell.
What are the main risks for CEVIY?
The main risks for CEVIY include its negative profitability, exposure to regulatory uncertainties in China, and limited liquidity on the OTC market. Economic slowdown in China and geopolitical tensions could also negatively impact the company's performance. Currency risk and increased competition from other asset management firms are additional factors to consider. Investors should carefully evaluate these risks before investing in CEVIY.
How is China Everbright Limited adapting to fintech disruption?
China Everbright Limited is adapting to fintech disruption by investing in artificial intelligence and other technology-driven solutions. The company is exploring opportunities to leverage fintech to improve its asset management capabilities and enhance customer service. However, the extent of its digital transformation initiatives and competitive response to fintech challengers requires further evaluation. The company's success in integrating fintech into its business model will be crucial for its long-term growth.
What regulatory challenges does China Everbright Limited face?
China Everbright Limited faces regulatory challenges related to its operations in Hong Kong and Mainland China. These challenges include compliance with capital requirements, anti-money laundering regulations, and investment restrictions. Changes in government policies and regulatory oversight could impact the company's business operations and financial performance. The company must navigate these regulatory complexities to maintain its competitive position and ensure compliance.
What are the key factors to evaluate for CEVIY?
China Everbright Limited (CEVIY) currently holds an AI score of 51/100, indicating moderate score. Key strength: Diversified investment portfolio across multiple sectors.. Primary risk to monitor: Ongoing: Negative P/E ratio and profit margin raise concerns about profitability.. This is not financial advice.
How frequently does CEVIY data refresh on this page?
CEVIY prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CEVIY's recent stock price performance?
Recent price movement in China Everbright Limited (CEVIY) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified investment portfolio across multiple sectors.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC data may be limited or unreliable.
- Financial data based on available information and may not be fully comprehensive.